WHO ICTRP trial

Antipsykotikas påvirkning af funktionelle kandidatendofænotyper for skizofreni…

EUCTR2008-002242-34-DK · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2008-002242-34-DK
Public title Antipsykotikas påvirkning af funktionelle kandidatendofænotyper for skizofreni: En prædiktor for outcome? - sertindol/risperidon projektet
Scientific title Antipsykotikas påvirkning af funktionelle kandidatendofænotyper for skizofreni: En prædiktor for outcome? - sertindol/risperidon projektet
Primary sponsor Center for neuropsykiatrisk Schrizofreniforskning
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): Therapeutic exploratory (Phase II): Therapeutic confirmatory - (Phase III): Therapeutic use (Phase IV): yes
Countries Denmark
Conditions Skizofreni Interventioner rettet mod specifikke skizofrene endofænotyper vil gøre det muligt at knytte skizofrene patienters deficits til deres kliniske symptomer og behandlingens udfald. Således at den heterogene gruppe af skizofrene…
Interventions Trade Name: Serdolect Pharmaceutical Form: Film-coated tablet Other descriptive name: sertindol Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 4- Other descriptive name: sertindol Concentration unit: mg…
Registration date Jun 30, 2008
Target size 48
Secondary IDs BG14-04-2008
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations